Николай Николаевич Семёнов
Moscow Clinical Scientific Center · 33 works · 13 citations · h-index 2
Top works
- FLOT compared to FOLFOX/XELOX as a neoadjuvant chemotherapy in locally advanced gastric cancer: Experience of two clinics.
- Comparison of the efficacy of neoadjuvant chemotherapy with FLOT regimen and adjuvant chemotherapy with XELOX/FOLFOX regimen in patients with locally advanced gastric cancer: A retrospective study
- Long-term outcomes of combined treatment of primary resectable pancreatic head cancer in patients over 70 years
- Prevalence of endothelial dysfunction and increased vascular stiffness in patients with solid malignancies
- Application of the Node-RADS system for evaluation of regional lymph nodes based on computed tomography data in colon cancer patients
- The results of the use of immune checkpoint inhibitors (ICI) pembrolizumab and nivolumab in the first line treatment of patients with metastatic gastric cancer. The experience of the oncological service of Moscow
- Evaluation of the Efficacy of Second-Line Therapy for Metastatic Gastric Cancer in Real Clinical Practice - the Results of a Multicenter Retrospective Study: Experience of Moscow Oncology Service
- The role of neoadjuvant chemotherapy in patients with primary resectable pancreatic cancer: A retrospective cohort study
- Оценка побочных эффектов двух режимов трехкомпонентной (капецитабин, оксалиплатин, иринотекан) химиотерапии диссеминированного колоректального рака в i линии лечения
- CLO26-090: Impact of Anti-VEGF therapies on Progression-Free and Overall Survival Following First- and Second-Line Chemotherapy in Left-Sided Colon and Rectal Cancer
- PNI and NRI are predictors of survival in advanced pancreatic cancer patients starting chemotherapy
- HALP and PINI are associated with the nutritional status and are independent risk factors of death at 3 months from the treatment start in advanced pancreatic cancer
- РЕЗУЛЬТАТЫ ПРИМЕНЕНИЯ ИНГИБИТОРОВ КОНТРОЛЬНЫХ ТОЧЕК (ИКТ) ПЕМБРОЛИЗУМАБ И НИВОЛУМАБ В III ЛИНИИ ЛЕЧЕНИЯ У ПАЦИЕНТОВ C МЕТАСТАТИЧЕСКИМ РАКОМ ЖЕЛУДКА. ОПЫТ ОНКОЛОГИЧЕСКОЙ СЛУЖБЫ Г. МОСКВЫ
- Роль гемцитабина (гемзара) в терапии неоперабельного немелкоклеточного рака легкого
- Успешное применение авастина и химиотерапии в комбинации с хирургическим лечением метастазов колоректального рака в печень у пожилого больного (описание случая)
- Metastatic adenocarcinomas of left colon and rectum: differences in clinical outcome and gene expression
- Адъювантная химиотерапия протоковой аденокарциномы поджелудочной железы режимами GEMCAP и mFOLFIRINOX: нежелательные явления и отдаленные результаты
- Role of adjuvant chemotherapy in patients with stage II-III ampullary cancer.
- Gastric cancer with bone metastases: Clinical and pathological characteristics
- Клиническая эффективность бондроната при метастазах в кости рака молочной железы